A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study

BACKGROUND: Several observational studies were conducted with vildagliptin in patients with type 2 diabetes mellitus (T2DM) fasting during Ramadan, showing significantly lower incidences of hypoglycemia with vildagliptin versus sulfonylureas, including gliclazide. It was of interest to complement th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanein, Mohamed, Abdallah, Khalifa, Schweizer, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045264/
https://www.ncbi.nlm.nih.gov/pubmed/24920915
http://dx.doi.org/10.2147/VHRM.S64038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045264/
https://www.ncbi.nlm.nih.gov/pubmed/24920915
http://dx.doi.org/10.2147/VHRM.S64038

Ejemplares similares